Pembrolizumab-induced myasthenia gravis: Two patients' experiences

• Main Authors: Leslie Montag (Author), Rachael Piver (Author), Amy Vidalin (Author), Marian Johnson (Author), Bunja Rungruang (Author), Robert Higgins (Author)
• Format: Book
• Published: Elsevier, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Checkpoint inhibitors are increasingly used to treat patients with gynecologic malignancies and can cause rare and unusual side effects, also known as immunotoxicities, that are rarely observed in patients receiving traditional immunotherapy. If these are not identified and treated, they can cause d...